Literature DB >> 479348

Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion.

P T Pullan, B H Clappison, C I Johnston.   

Abstract

Using sensitive specific RIAs for vasopressin (AVP) and the two major human neurophysins, the relationship between AVP and the individual human neurophysins was investigated in man by measuring changes in plasma concentrations in physiological and pathological states known to be associated with changes in AVP secretion. Dehydration, water loading, and hemorrhage produced small but significant changes in plasma AVP concentrations without changes in the individual human neurophysins. In response to the stimulus of cigarette smoke inhalation, large parallel changes in plasma AVP and human neurophysin I (HNPI) levels were seen without change in plasma human neurophysin II (HNPII) levels. In the pathological states of diabetes insipidus and the syndrome of inappropriate antidiuretic hormone secretion,the observations more strongly supported a specific association between AVP and NHPI. In eight patients with central diabetes insipidus, plasma AVP and HNPI levels were low or undetectable, while plasma HNPII levels were normal. There was a clear distinction of both plasma AVP and HNPI levels in patients with central diabetes insipidus and those in patients whti nephrogenic diabetes insipidus. In 14 patients with the syndrome of inappropriate antidiuretic hormone secretion due to causes other than ectopic AVP production from tumors, plasma AVP and HNPI levels were elevated or normal, while plasma HNPII levels were normal. There was a highly significant positive correlation (r = 0.99) between plasma AVP and HNPI levels in these patients, with a 1:1 molar ratio. These data suggest that the secretion of AVP and HNPI in man are functionally related, while the secretion of HNPII is independent of AVP secretion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479348     DOI: 10.1210/jcem-49-4-580

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Effect of histaminergic H1- and H2-receptor antagonists on neurophysin release in response to nicotine from cigarette smoking in normal men.

Authors:  P Chiodera; G Rossi; L Camellini; M L Maffei; R Volpi; V Coiro
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

2.  Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction.

Authors:  P Chiodera; F Louis; J J Legros
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

3.  Neuroendocrine reactivity to nicotine in smokers.

Authors:  O F Pomerleau; J B Fertig; L E Seyler; J Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Cerebrospinal fluid neurophysins in affective illness and in schizophrenia.

Authors:  P Linkowski; V Geenen; M Kerkhofs; J Mendlewicz; J J Legros
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

5.  Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.

Authors:  J Boldt; T Menges; D Kuhn; C Diridis; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

6.  Degradation of Premature-miR-181b by the Translin/Trax RNase Increases Vascular Smooth Muscle Cell Stiffness.

Authors:  Eric Tuday; Mitsunori Nakano; Kei Akiyoshi; Xiuping Fu; Aparna P Shah; Atsushi Yamaguchi; Charles Steenbergen; Lakshmi Santhanam; Steven S An; Dan Berkowitz; Jay M Baraban; Samarjit Das
Journal:  Hypertension       Date:  2021-07-26       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.